Structural Analysis of Prion Proteins by Means of Drift Cell and Traveling Wave Ion Mobility Mass Spectrometry

Overview

Journal J Am Soc Mass Spectrom

Specialty Chemistry

Date 2010 Mar 9

PMID 20206551

Citations 16

Authors

Gillian R Hilton

Konstantinos Thalassinos

Megan Grabenauer

Narinder Sanghera

Susan E Slade

Thomas Wyttenbach

Philip J Robinson

Teresa J T Pinheiro

Michael T Bowers

James H Scrivens

Affiliations

Soon will be listed here.

Abstract

The prion protein (PrP) is implicitly involved in the pathogenesis of transmissible spongiform encephalopathies (TSEs). The conversion of normal cellular PrP (PrP(C)), a protein that is predominantly alpha-helical, to a beta-sheet-rich isoform (PrP(Sc)), which has a propensity to aggregate, is the key molecular event in prion diseases. During its short life span, PrP can experience two different pH environments; a mildly acidic environment, whilst cycling within the cell, and a neutral pH when it is glycosyl phosphatidylinositol (GPI)-anchored to the cell membrane. Ion mobility (IM) combined with mass spectrometry has been employed to differentiate between two conformational isoforms of recombinant Syrian hamster prion protein (SHaPrP). The recombinant proteins studied were alpha-helical SHaPrP(90-231) and beta-sheet-rich SHaPrP(90-231) at pH 5.5 and pH 7.0. The recombinant proteins have the same nominal mass-to-charge ratio (m/z) but differ in their secondary and tertiary structures. A comparison of traveling-wave (T-Wave) ion mobility and drift cell ion mobility (DCIM) mass spectrometry estimated and absolute cross-sections showed an excellent agreement between the two techniques. The use of T-Wave ion mobility as a shape-selective separation technique enabled differentiation between the estimated cross-sections and arrival time distributions (ATDs) of alpha-helical SHaPrP(90-231) and beta-sheet-rich SHaPrP(90-231) at pH 5.5. No differences in cross-section or ATD profiles were observed between the protein isoforms at pH 7.0. The findings have potential implications for a new ante-mortem screening assay, in bodily fluids, for prion misfolding diseases such as TSEs.

Citing Articles

Transient multimers modulate conformer abundances of prion protein monomer through conformational selection.

Rest G, Rezaei H, Halgand F Sci Rep. 2019; 9(1):12159.

PMID: 31434938 PMC: 6704068. DOI: 10.1038/s41598-019-48377-w.

Interpreting the Collision Cross Sections of Native-like Protein Ions: Insights from Cation-to-Anion Proton-Transfer Reactions.

Laszlo K, Bush M Anal Chem. 2017; 89(14):7607-7614.

PMID: 28636334 PMC: 5589449. DOI: 10.1021/acs.analchem.7b01474.

Native-Like and Denatured Cytochrome c Ions Yield Cation-to-Anion Proton Transfer Reaction Products with Similar Collision Cross-Sections.

Laszlo K, Buckner J, Munger E, Bush M J Am Soc Mass Spectrom. 2017; 28(7):1382-1391.

PMID: 28224394 PMC: 5555649. DOI: 10.1007/s13361-017-1620-4.

Ion Mobility Collision Cross Section Compendium.

May J, Morris C, McLean J Anal Chem. 2016; 89(2):1032-1044.

PMID: 28035808 PMC: 5744664. DOI: 10.1021/acs.analchem.6b04905.

Monitoring Conformational Landscape of Ovine Prion Protein Monomer Using Ion Mobility Coupled to Mass Spectrometry.

Rest G, Rezaei H, Halgand F J Am Soc Mass Spectrom. 2016; 28(2):303-314.

PMID: 27757822 DOI: 10.1007/s13361-016-1522-x.

References

Whittal R, Ball H, Cohen F, Burlingame A, Prusiner S, Baldwin M . Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci. 2000; 9(2):332-43. PMC: 2144551. DOI: 10.1110/ps.9.2.332. View

Grabenauer M, Wyttenbach T, Sanghera N, Slade S, Pinheiro T, Scrivens J . Conformational stability of Syrian hamster prion protein PrP(90-231). J Am Chem Soc. 2010; 132(26):8816-8. PMC: 2902166. DOI: 10.1021/ja100243h. View

Donne D, Viles J, Groth D, Mehlhorn I, James T, Cohen F . Structure of the recombinant full-length hamster prion protein PrP(29-231): the N terminus is highly flexible. Proc Natl Acad Sci U S A. 1998; 94(25):13452-7. PMC: 28326. DOI: 10.1073/pnas.94.25.13452. View

Wyttenbach T, Grabenauer M, Thalassinos K, Scrivens J, Bowers M . The effect of calcium ions and peptide ligands on the relative stabilities of the calmodulin dumbbell and compact structures. J Phys Chem B. 2009; 114(1):437-47. DOI: 10.1021/jp906242m. View

Back J, Sanz M, de Jong L, de Koning L, Nijtmans L, de Koster C . A structure for the yeast prohibitin complex: Structure prediction and evidence from chemical crosslinking and mass spectrometry. Protein Sci. 2002; 11(10):2471-8. PMC: 2373692. DOI: 10.1110/ps.0212602. View

Collinge J, Palmer M . Prion diseases. Curr Opin Genet Dev. 1992; 2(3):448-54. DOI: 10.1016/s0959-437x(05)80156-x. View

Ruotolo B, Benesch J, Sandercock A, Hyung S, Robinson C . Ion mobility-mass spectrometry analysis of large protein complexes. Nat Protoc. 2008; 3(7):1139-52. DOI: 10.1038/nprot.2008.78. View

Goormaghtigh E, Cabiaux V, Ruysschaert J . Secondary structure and dosage of soluble and membrane proteins by attenuated total reflection Fourier-transform infrared spectroscopy on hydrated films. Eur J Biochem. 1990; 193(2):409-20. DOI: 10.1111/j.1432-1033.1990.tb19354.x. View

Khamsi R . Prion disease: the shape of things to come. Nature. 2006; 439(7073):134-5. DOI: 10.1038/439134a. View

10.

Thalassinos K, Grabenauer M, Slade S, Hilton G, Bowers M, Scrivens J . Characterization of phosphorylated peptides using traveling wave-based and drift cell ion mobility mass spectrometry. Anal Chem. 2009; 81(1):248-54. DOI: 10.1021/ac801916h. View

11.

Dabaghian R, Mortimer P, Clewley J . Prospects for the development of pre-mortem laboratory diagnostic tests for Creutzfeldt-Jakob disease. Rev Med Virol. 2004; 14(6):345-61. DOI: 10.1002/rmv.450. View

12.

Ruotolo B, Giles K, Campuzano I, Sandercock A, Bateman R, Robinson C . Evidence for macromolecular protein rings in the absence of bulk water. Science. 2005; 310(5754):1658-61. DOI: 10.1126/science.1120177. View

13.

Borchelt D, Scott M, Taraboulos A, Stahl N, Prusiner S . Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol. 1990; 110(3):743-52. PMC: 2116048. DOI: 10.1083/jcb.110.3.743. View

14.

Pushie M, Ross A, Vogel H . Mass spectrometric determination of the coordination geometry of potential copper(II) surrogates for the mammalian prion protein octarepeat region. Anal Chem. 2007; 79(15):5659-67. DOI: 10.1021/ac070312l. View

15.

Caughey B, Raymond G . The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem. 1991; 266(27):18217-23. View

16.

Prusiner S . Prions. Proc Natl Acad Sci U S A. 1998; 95(23):13363-83. PMC: 33918. DOI: 10.1073/pnas.95.23.13363. View

17.

Li J, Browning S, Mahal S, Oelschlegel A, Weissmann C . Darwinian evolution of prions in cell culture. Science. 2010; 327(5967):869-72. PMC: 2848070. DOI: 10.1126/science.1183218. View

18.

Maras B, Barra D, Schinina M, Cardone F, Pocchiari M . Prion (PrPres) allotypes profiling: a new perspectives from mass spectrometry. Eur J Mass Spectrom (Chichester). 2004; 10(3):371-82. DOI: 10.1255/ejms.602. View

19.

Riek R, Hornemann S, Wider G, Glockshuber R, Wuthrich K . NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett. 1997; 413(2):282-8. DOI: 10.1016/s0014-5793(97)00920-4. View

20.

Ironside J, Bishop M, Connolly K, Hegazy D, Lowrie S, Le Grice M . Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ. 2006; 332(7551):1186-8. PMC: 1463905. DOI: 10.1136/bmj.38804.511644.55. View